NasdaqGS - Delayed Quote • USD
HilleVax, Inc. (HLVX)
At close: May 31 at 4:00 PM EDT
After hours: May 31 at 4:20 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Robert M. Hershberg M.D., Ph.D. | President, CEO & Chairman of the Board | 1.04M | -- | 1962 |
| Ms. Astrid Borkowski M.D., Ph.D. | Chief Medical Officer | 854.56k | -- | 1970 |
| Dr. Aditya Kohli Ph.D. | Chief Business Officer & Director | 765.87k | -- | 1988 |
| Mr. Shane A. Maltbie | CFO & Treasurer | -- | -- | 1982 |
| Mr. Sean McLoughlin | Chief Operating Officer | -- | -- | 1972 |
| Dr. Anju Chatterji Ph.D. | Chief Technology Officer | -- | -- | -- |
| Mr. Paul S. Bavier J.D. | General Counsel, Secretary & Chief Administrative Officer | -- | -- | 1972 |
| Mr. Ozzie Berger | Senior Vice President of Regulatory Affairs | -- | -- | -- |
HilleVax, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 90
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Corporate Governance
HilleVax, Inc.’s ISS Governance QualityScore as of June 1, 2024 is 9. The pillar scores are Audit: 3; Board: 10; Shareholder Rights: 8; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
AVTE Aerovate Therapeutics, Inc.
17.45
-1.19%
THRD Third Harmonic Bio, Inc.
13.31
-2.49%
ELVN Enliven Therapeutics, Inc.
22.57
+0.13%
KYTX Kyverna Therapeutics, Inc.
12.53
+1.70%
ORIC ORIC Pharmaceuticals, Inc.
8.99
+0.67%
PEPG PepGen Inc.
16.33
-0.12%
LRMR Larimar Therapeutics, Inc.
8.00
+12.68%
LXEO Lexeo Therapeutics, Inc.
16.63
+3.61%
TRDA Entrada Therapeutics, Inc.
15.47
-1.02%
ENGN enGene Holdings Inc.
8.79
-16.29%